• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Biomarin Pharmaceutical

Biomarin Pharmaceutical

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Cure Duchenne Ventures LLC Provides $1 Million to MyoTherix to Advance Promising Research to Treat Duchenne Muscular Dystrophy

    Cure Duchenne Ventures LLC Provides $1 Million to MyoTherix to Advance Promising Research to Treat Duchenne Muscular Dystrophy

  2. Bull case strengthens as summer cross currents -2-

    Bull case strengthens as summer cross currents -2-

  3. MSCI Equity Indexes August 2015 Index Review

    MSCI Equity Indexes August 2015 Index Review

  4. UPDATE: Charting the U.S. markets' technical -2-

    UPDATE: Charting the U.S. markets' technical -2-

  5. Charting the U.S. markets' technical cross -2-

    Charting the U.S. markets' technical cross -2-

  6. Investing in Hidden Assets

    Use this screen to find high-growth businesses that have big ideas to keep competitors at bay.

  7. A Young Power Couple's Kickstart Portfolio

    With "massive" student debt loads receding in the rearview mirror, a young professional couple fires up their investment plan.

  8. Our Outlook for Health-Care Stocks

    Health-care stocks are on a tear as demand slowly returns.

  9. Our Outlook for Health-Care Stocks

    While we remain bullish on the sector, health-care growth depends on the economy.

  10. Our Outlook for Health-Care Stocks

    With two years of stellar returns behind us, our expectations for 2013 are more muted, but some opportunities persist.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.